3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
2
Suspended
1
Enrolling by invitation
1
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
13
Brain Neoplasms
9
Prostatic Neoplasms
7
Neoplasms
7
Head and Neck Neoplasms
6
Motor Activity
4
Glioma
4
Glioblastoma
4
Triple Negative Breast Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pain
3
Colorectal Neoplasms
3
Quality of Life
2
Papillomavirus Infections
2
Pancreatic Neoplasms
2
Obesity
2
Multiple Myeloma
2
Melanoma
2
Lymphoma, Follicular
2
Gastrointestinal Neoplasms
2
Esophageal Neoplasms
2
Depression
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Cancer Pain
2
Biliary Tract Neoplasms
2
Behavior
2
Weight Loss
1
Venous Thromboembolism
1
Ureteral Neoplasms
1
Interventions
tocilizumab
1
lopinavir-ritonavir drug combination
1
Piperacillin, Tazobactam Drug Combination
1
Oxygen Inhalation Therapy
1
Methylprednisolone
1
Lopinavir
1
Hydroxychloroquine
1
Heparin, Low-Molecular-Weight
1
Azithromycin
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Suspended
×
Cytokine Release Syndrome
×
Clear all
NCT04394182
2022-03-29
ULTRA-COVID
Fundacion GenesisCare
Phase NA
Suspended
15 enrolled